Cetera Trust Company N.A Has $74,000 Stock Holdings in Evolent Health, Inc. (NYSE:EVH)

Cetera Trust Company N.A decreased its position in shares of Evolent Health, Inc. (NYSE:EVH) by 29.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,600 shares of the technology company’s stock after selling 2,730 shares during the period. Cetera Trust Company N.A’s holdings in Evolent Health were worth $74,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also made changes to their positions in the company. Covestor Ltd boosted its position in shares of Evolent Health by 138.1% during the 3rd quarter. Covestor Ltd now owns 1,424 shares of the technology company’s stock worth $40,000 after acquiring an additional 826 shares in the last quarter. GAMMA Investing LLC boosted its position in Evolent Health by 5,365.5% in the third quarter. GAMMA Investing LLC now owns 1,585 shares of the technology company’s stock valued at $45,000 after buying an additional 1,556 shares in the last quarter. Quarry LP acquired a new stake in Evolent Health in the second quarter valued at approximately $32,000. Canada Pension Plan Investment Board acquired a new stake in Evolent Health in the second quarter valued at approximately $61,000. Finally, Point72 Asia Singapore Pte. Ltd. boosted its position in Evolent Health by 2,471.9% in the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 6,507 shares of the technology company’s stock valued at $184,000 after buying an additional 6,254 shares in the last quarter.

Evolent Health Price Performance

Shares of NYSE EVH opened at $10.03 on Wednesday. Evolent Health, Inc. has a twelve month low of $9.88 and a twelve month high of $35.00. The firm has a fifty day simple moving average of $11.60 and a 200 day simple moving average of $20.59. The company has a market capitalization of $1.17 billion, a PE ratio of -11.05 and a beta of 1.45. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.58.

Evolent Health (NYSE:EVH) last posted its quarterly earnings results on Thursday, November 7th. The technology company reported ($0.08) earnings per share for the quarter, missing the consensus estimate of $0.30 by ($0.38). Evolent Health had a negative net margin of 2.93% and a positive return on equity of 6.30%. The company had revenue of $621.40 million during the quarter, compared to the consensus estimate of $625.58 million. During the same period last year, the firm posted $0.19 earnings per share. On average, sell-side analysts forecast that Evolent Health, Inc. will post 0.26 EPS for the current year.

Wall Street Analyst Weigh In

A number of analysts have weighed in on EVH shares. JPMorgan Chase & Co. cut their target price on shares of Evolent Health from $45.00 to $15.00 and set an “overweight” rating on the stock in a research report on Friday, November 22nd. Oppenheimer cut their target price on shares of Evolent Health from $34.00 to $28.00 and set an “outperform” rating on the stock in a research report on Monday, November 18th. BTIG Research dropped their price target on shares of Evolent Health from $36.00 to $29.00 and set a “buy” rating for the company in a research note on Tuesday, December 3rd. UBS Group dropped their price target on shares of Evolent Health from $27.00 to $14.00 and set a “buy” rating for the company in a research note on Thursday, January 16th. Finally, Royal Bank of Canada dropped their price target on shares of Evolent Health from $20.00 to $17.00 and set an “outperform” rating for the company in a research note on Tuesday, January 14th. One research analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, Evolent Health presently has an average rating of “Buy” and a consensus target price of $21.62.

Evolent Health Company Profile

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.